Press Releases: 2010
Fluxion Announces Opening of 2010 BioFlux Innovation Award
5/5/2010
Applications now being accepted for a chance to win a free BioFlux system
SOUTH SAN FRANCISCO--(BUSINESS WIRE)-- Fluxion Biosciences, a leading developer of microfluidic systems for functional cell analysis, today announced the launch of its 2010 BioFlux Innovation Award. This program allows scientists from all around the world to submit innovative research ideas using the BioFlux system for live cell imaging under controlled physiological flow conditions. The BioFlux enables a diverse range of applications in fields such as oncology, immunology, cardiovascular biology, microbiology, and stem cells.
Applications may be submitted from May 1 through July 31, 2010. Ten finalists will be selected and one winner will be awarded a free BioFlux 200 system. Applications will be judged on innovation, creativity, and utilization of the BioFlux technology. All individuals and groups who conduct original research and drug discovery are encouraged to apply.
Applications can be submitted online at: www.fluxionbio.com/BFIA2010.
"We are very excited to launch this program and look forward to reviewing the applications,” commented Mike Schwartz, Program Director at Fluxion Biosciences. “The BioFlux brings a wide range of capabilities to researchers in many different fields. Our goal for this program is to highlight the many different uses people are discovering for the BioFlux, and to expand these possibilities even further.”
About Fluxion Biosciences
Fluxion Biosciences provides cellular analysis tools for use in critical life science research and drug discovery applications. Fluxion’s proprietary microfluidic platform enables precise functional analysis of individual cells in a multiplexed format. Fluxion’s systems meet the rigorous demands of life science and drug discovery scientists by providing an intuitive, easy-to-use operating system for single-cell biology. For more information about Fluxion Biosciences, visit www.fluxionbio.com.
Contact
Michael Schwartz, Program Director
Fluxion Biosciences
384 Oyster Point Blvd. #6
South San Francisco, CA 94080
650-241-4777
mike.schwartz@fluxionbio.com